Workflow
智能麻醉辅助机器人
icon
Search documents
调研速递|中科院成都信息技术股份有限公司接受27家机构调研,透露业务突破方向等要点
Xin Lang Zheng Quan· 2025-09-04 15:54
Core Viewpoint - The company focuses on breakthroughs in intelligent manufacturing and smart city solutions, leveraging high-speed machine vision and big data technologies to provide services across various sectors [2]. Group 1: Business Focus - The company's main business revolves around high-speed machine vision and big data core technologies, providing information technology engineering and related product services for smart governance and intelligent manufacturing [2]. - The company emphasizes the application of its core technologies in more niche areas, particularly in intelligent manufacturing and smart city initiatives [2]. Group 2: Robotics Business - The intelligent loading robot for smart construction integrates machine vision and radar technologies, achieving a precision recognition capability of 5 cm, which is ahead of domestic standards [3]. - The robot can operate collaboratively without human control and can work 24 hours a day in the absence of lighting, with successful trials conducted with road and bridge groups [3]. - The intelligent anesthesia assistance robot has completed its first clinical trial, providing new solutions for surgical anesthesia applicable in various hospitals [3]. Group 3: Growth in Trustworthy Innovation Field - The company has made significant strides in the trustworthy innovation sector, particularly in smart governance, with the digital conference system achieving localization [4]. - Multiple projects have been delivered to provincial and municipal levels, enhancing government information technology [4]. - The company is actively working on platform localization modifications and has completed adaptation certifications [4]. Group 4: Capital Operations and R&D Investment - The company prioritizes capital operations and plans to utilize various financing methods to promote the industrialization of research outcomes [5]. - The annual R&D investment is approximately 40 million yuan, accounting for 6% to 8% of operating revenue, with a 15.74% year-on-year increase in R&D expenses this year [5]. - The company is developing brain-computer interface technologies for applications in intelligent anesthesia and smart rehabilitation, with its core machine vision technology being internationally advanced and domestically leading [5].